Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Health Canada has completed its quality review of the shipment of Janssen vaccines that are currently in quarantine. To protect the health and safety of Canadians in response to concerns regarding a ...
read more
Following careful review and deliberation, the U.S. FDA is taking important steps that will allow a critically needed supply of the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available.
read more
The U.S. FDA issued a safety communication warning the public to stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test for diagnostic use. The FDA has significant concerns that the ...
read more
Novavax Inc announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met ...
read more
The National Institutes of Health’s (NIH) National Cancer Institute (NCI) has awarded Vibrent Health, a digital health technology company powering the future of precision health research, the second ...
read more
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [...
read more
Real-world data from PHE, published as a pre-print, demonstrated two doses of COVID-19 Vaccine AstraZeneca are 92% effective against hospitalization due to the Delta variant and showed no deaths among...
read more
AstraZeneca announced results from the STORM CHASER trial assessing the safety and efficacy of AZD7442, a long-acting antibody (LAAB) combination, for the prevention of symptomatic COVID-19 in ...
read more
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 160 million people worldwide. Researchers have targeted the SARS-CoV-2 structural ...
read more
Moderna Inc. and Magenta Investments, a leading pharmaceutical and healthcare company based in the United Arab Emirates (UAE), announced a new agreement to distribute the Moderna COVID-19 Vaccine as ...
read more
Continuously surging numbers of global COVID-19 cases caused by rapidly emerging SARS-CoV-2 mutants forming more contagious and deadly viral strains force our scientific capacity to find creative ways...
read more
The European Commission had requested 120 million vaccine doses cumulatively by the end of June 2021, and a total of 300 million doses by the end of September 2021. The judge ordered delivery of 80.2...
read more
Avacta Group plc announced that it has entered into a non-exclusive distribution agreement with Calibre Scientific Inc. for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test for use in the UK and ...
read more
The cobas SARS-CoV-2 test is the first RT-PCR test that screens within 20 minutes both asymptomatic and symptomatic persons, enabling quick, informed decisions at the point of care. The test is for ...
read more
Historically, the development of controlled release products has been predominantly driven by brand owners’ strategies to extend a product life cycle by developing controlled release variations of ...
read more